Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

A step forward for unraveling the immune mechanisms and tools for tuberculosis spectrum management

Project description

Immune mechanisms across the tuberculosis spectrum

Tuberculosis (TB) is not a uniform disease but encompasses a spectrum of symptoms, ranging from latent infection with no symptoms to subclinical stages and active disease. Understanding how the immune system interacts with Mycobacterium tuberculosis across this spectrum is essential for predicting disease progression and for developing improved diagnostics. With the support of the Marie Skłodowska-Curie Actions programme, the TB-SPECTRUM project will bring together a multidisciplinary international consortium to investigate the immune mechanisms underlying TB spectrum transitions. The key objective is to identify biomarkers of disease progression, enhance translational research capacity and strengthen innovation in the field.

Objective

TB-SPECTRUM aims to strengthen international research collaboration among different sectors and disciplines, and to structure a network to perform high-quality, translational, and multidisciplinary research for (i) a better understanding of tuberculosis (TB) spectrum immune mechanisms; and (ii) increasing the capacities of the involved staff fostering training and networking activities, as well as increasing their inter-sectoral employability opportunities. Understanding the host-pathogen interactions in the different phases of the spectrum is fundamental for detecting biomarkers of disease progression that can lead to new diagnostic approaches for identifying those individuals with a high-risk of developing disease if infected or for detecting subclinical TB forms. However, it is still unknown which immunological mechanisms are involved in infection/disease progression. To unravel this knowledge gap, it is mandatory to develop collaborative research which combines different expertise in the TB field (clinics, diagnostics, treatment, clinical studies management, cellular/humoral immunology, genomics, and technology transfer, among others). For that purpose, a Consortium of nine academic and non-academic Institutions harboring TB-renowned experts has been constituted. This network is formed by specialists in the clinical management of active TB cases and their contacts (from high and low incident countries); experts in basic/applied science; and a small and medium-sized enterprise (SME) involved in the development of immune assays. Altogether, the proposed goals will be achieved through secondments among the different sectors, which will be extremely important for progressing to a better understanding of the requirements needed in TB management and control; and will expose participants to new research environments that will reinforce multidisciplinarity. Moreover, the interaction with an SME will improve knowledge transference skills, stimulating entrepreneurship.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-SE - HORIZON TMA MSCA Staff Exchanges

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2024-SE-01

See all projects funded under this call

Coordinator

INSTITUT DE INVESTIGACIO EN CIENCIES DE LA SALUT GERMANS TRIAS I PUJOL
Net EU contribution
€ 260 520,00
Address
CTRA DE CANYET S/N
08916 Badalona Barcelona
Spain
Region
Este Cataluña Barcelona
Activity type
Research Organisations
Links
Total cost
No data

Participants (6)

Partners (2)